- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07575399
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
A Phase 3, Open-label Trial to Evaluate the Efficacy, Safety and Tolerability of Switching From the Glucagon-like Peptide-1 Receptor Agonists to Maridebart Cafraglutide in Adult Participants With Obesity or Overweight
Efficacy, safety and tolerability of switching from GLP-1RA to maridebart cafraglutide in adults with obesity or overweight.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Fas 3
Kontakter och platser
Studiekontakt
- Namn: Amgen Call Center
- Telefonnummer: 866-572-6436
- E-post: medinfo@amgen.com
Studieorter
-
-
Alabama
-
Pelham, Alabama, Förenta staterna, 35124
- Rekrytering
- Cahaba Research, Inc.
-
-
Arizona
-
Chandler, Arizona, Förenta staterna, 85224
- Rekrytering
- Arizona Clinical Trials
-
Sun City, Arizona, Förenta staterna, 85351
- Rekrytering
- Epic Medical Research - Sun City
-
Sun City West, Arizona, Förenta staterna, 85375
- Rekrytering
- Clinical Research Institute of Arizona LLC
-
-
California
-
Chula Vista, California, Förenta staterna, 91911
- Rekrytering
- Peninsula Research Associates
-
Palm Springs, California, Förenta staterna, 92262
- Rekrytering
- Desert Oasis Healthcare Medical Group
-
Rialto, California, Förenta staterna, 92377
- Rekrytering
- Inland Empire Liver Foundation
-
San Diego, California, Förenta staterna, 92120
- Rekrytering
- Apex Clinical Research
-
Santa Ana, California, Förenta staterna, 92701
- Rekrytering
- Southern California Clinical Research
-
-
Florida
-
Gainesville, Florida, Förenta staterna, 32610
- Rekrytering
- University of Florida Department of Medicine
-
Hialeah, Florida, Förenta staterna, 33012
- Rekrytering
- Aga Clinical Trials
-
Margate, Florida, Förenta staterna, 33063
- Rekrytering
- South Florida Clinical Research
-
Miami, Florida, Förenta staterna, 33165
- Rekrytering
- New Horizon Research Center
-
Miami, Florida, Förenta staterna, 33173
- Rekrytering
- Research Institute of South Florida
-
Mt. Dora, Florida, Förenta staterna, 32757
- Rekrytering
- Adult Medicine of Lake County
-
Orlando, Florida, Förenta staterna, 32801
- Rekrytering
- Clinical Neuroscience Solutions
-
Orlando, Florida, Förenta staterna, 32825
- Rekrytering
- Florida Institute for Clinical Research
-
Port Orange, Florida, Förenta staterna, 32127
- Rekrytering
- Progressive Medical Research
-
The Villages, Florida, Förenta staterna, 32162
- Rekrytering
- Charter Research - The Villages
-
-
Georgia
-
Canton, Georgia, Förenta staterna, 30114
- Rekrytering
- East Coast Institute for Research
-
Johns Creek, Georgia, Förenta staterna, 30024
- Rekrytering
- Nsc Research
-
Union City, Georgia, Förenta staterna, 30291
- Rekrytering
- Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group
-
Woodstock, Georgia, Förenta staterna, 30189
- Rekrytering
- North Georgia Clinical Research
-
-
Hawaii
-
Kapolei, Hawaii, Förenta staterna, 96707
- Rekrytering
- Mel A. Ona, M.D., Incorporated
-
-
Idaho
-
Meridian, Idaho, Förenta staterna, 83646
- Rekrytering
- Solaris Clinical Research
-
-
Illinois
-
Skokie, Illinois, Förenta staterna, 60077
- Rekrytering
- Endeavor Health
-
Springfield, Illinois, Förenta staterna, 62704
- Rekrytering
- Central Illinois Diabetes and Clinical Research, a Division of Prairie Education and Research Cooper
-
-
Kansas
-
Lenexa, Kansas, Förenta staterna, 66219
- Rekrytering
- Johnson County Clinical Trials
-
-
Louisiana
-
Baton Rouge, Louisiana, Förenta staterna, 70808
- Rekrytering
- Pennington Biomedical Research Center
-
-
Michigan
-
Southfield, Michigan, Förenta staterna, 48034
- Rekrytering
- Great Lakes Research Institute
-
Troy, Michigan, Förenta staterna, 48098
- Rekrytering
- Arcturus Healthcare, Public Limited Company, Troy Internal Medicine Research Division
-
-
Mississippi
-
Ridgeland, Mississippi, Förenta staterna, 39157
- Rekrytering
- Sky Integrative Medical Center
-
-
Montana
-
Missoula, Montana, Förenta staterna, 59808
- Rekrytering
- Montana Medical Research
-
-
Nevada
-
Las Vegas, Nevada, Förenta staterna, 89109
- Rekrytering
- Excel Clinical Research
-
-
New York
-
New York, New York, Förenta staterna, 10029
- Rekrytering
- Icahn School of Medicine at Mount Sinai
-
Rochester, New York, Förenta staterna, 14609
- Rekrytering
- Rochester Clinical Research
-
-
North Carolina
-
Morehead City, North Carolina, Förenta staterna, 28557
- Rekrytering
- Centricity Research Morehead City Specialty
-
Raleigh, North Carolina, Förenta staterna, 27609
- Rekrytering
- Accellacare of Raleigh
-
Wilmington, North Carolina, Förenta staterna, 28401
- Rekrytering
- Accellacare Research of Wilmington
-
-
Oklahoma
-
Chickasha, Oklahoma, Förenta staterna, 73018
- Rekrytering
- Epic Medical Research - Oklahoma
-
Oklahoma City, Oklahoma, Förenta staterna, 73112
- Rekrytering
- Lynn Health Science Institute
-
-
Pennsylvania
-
Beaver, Pennsylvania, Förenta staterna, 15009
- Rekrytering
- Heritage Valley Multispecialty Group Inc
-
Duncansville, Pennsylvania, Förenta staterna, 16635
- Rekrytering
- Altoona Center for Clinical Research
-
-
Texas
-
Austin, Texas, Förenta staterna, 78757
- Rekrytering
- Pinnacle Clinical Research Georgetown
-
DeSoto, Texas, Förenta staterna, 75115
- Rekrytering
- Epic Medical Research - DeSoto
-
Edinburg, Texas, Förenta staterna, 78539
- Avslutad
- South Texas Research Institute
-
Houston, Texas, Förenta staterna, 77043
- Rekrytering
- Biopharma Informatic, LLC
-
Houston, Texas, Förenta staterna, 77089
- Rekrytering
- Research Physicians Network, LLC
-
McAllen, Texas, Förenta staterna, 78503
- Rekrytering
- Biopharma Informatic-McAllen
-
McKinney, Texas, Förenta staterna, 75071
- Rekrytering
- Texas Institute of Cardiology
-
North Richland Hills, Texas, Förenta staterna, 76180
- Rekrytering
- North Hills Medical Research
-
San Antonio, Texas, Förenta staterna, 78215
- Rekrytering
- American Research Corporation
-
San Antonio, Texas, Förenta staterna, 78230
- Rekrytering
- VIP Trials
-
San Antonio, Texas, Förenta staterna, 78229
- Rekrytering
- Gastroenterology Clinic of San Antonio PA
-
Tomball, Texas, Förenta staterna, 77375
- Rekrytering
- Northwest Houston Heart Center
-
-
Washington
-
Redmond, Washington, Förenta staterna, 98052
- Rekrytering
- Eastside Research Associates Health Research
-
-
-
-
-
Ponce, Puerto Rico, 00717
- Rekrytering
- Puerto Rico Medical Research Inc.
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Body Mass Index (BMI) ≥ 25 at screening.
- Weight loss of ≥ 10% on weekly GLP-1 RA.
- Stable body weight.
- Stable dose of GLP-1RA.
- Stable gastrointestinal (GI) tolerability.
- Contraception for females.
- Willingness to follow trial procedures for the duration of the trial.
Exclusion Criteria:
- Obesity induced by other endocrine disorders (ex: Cushing's syndrome).
- Previous or planned surgical, endoscopic or device-based treatment for obesity.
- History of malignancy.
- Type 1/Type 2 diabetes mellitus (DM).
- Family or personal history of medullary thyroid cancer.
- Previous participation in a Maridebart Cafraglutide trial.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: MariTide Arm 1
Participants will receive maridebart cafraglutide dosing schedule 1 during the treatment period. |
Maridebart cafraglutide will be administered via subcutaneous (SC) injection.
Andra namn:
|
|
Experimentell: MariTide Arm 2
Participants will receive maridebart cafraglutide dosing schedule 2 during the treatment period. |
Maridebart cafraglutide will be administered via subcutaneous (SC) injection.
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Percent Change from Baseline in Body Weight at Week 68
Tidsram: Week 68
|
Week 68
|
Sekundära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Percent Change in Body Weight Prior to the Start of Weekly GLP-1RA at Week 68
Tidsram: Week 68
|
Week 68
|
|
Percentage of Participants Maintaining ≥ 80% of the Body Weight Reduction Achieved with Prior Weekly GLP-1RA Treatment at Week 68
Tidsram: Week 68
|
Week 68
|
|
Percent Maintenance of the Body Weight Reduction Achieved with Prior Weekly GLP-1RA Treatment at Week 68
Tidsram: Week 68
|
Week 68
|
|
Plasma Concentration of Maridebart Cafraglutide at Week 68
Tidsram: Week 68
|
Week 68
|
|
Number of Participants with Treatment-emergent Adverse Events and Serious Adverse Events
Tidsram: Up to 84 weeks
|
Up to 84 weeks
|
Samarbetspartners och utredare
Sponsor
Utredare
- Studierektor: MD, Amgen
Publikationer och användbara länkar
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 20250036
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
De-identified individual patient data for variables necessary to address the specific research question in an approved data sharing request.
Tidsram för IPD-delning
Data sharing requests relating to this trial will be considered beginning 18 months after the trial has ended and either 1) the product and indication (or other new use) have been granted marketing authorization in both the US and Europe, or 2) clinical development for the product and/or indication discontinues and the data will not be submitted to regulatory authorities. There is no end date for eligibility to submit a data sharing request for this trial.
Kriterier för IPD Sharing Access
Qualified researchers may submit a request containing the research objectives, the Amgen product(s) and Amgen trial/trials in scope, endpoints/outcomes of interest, statistical analysis plan, data requirements, publication plan, and qualifications of the researcher(s). In general, Amgen does not grant external requests for individual patient data for the purpose of re-evaluating safety and efficacy issues already addressed in the product labelling. Requests are reviewed by a committee of internal advisors, and if not approved, may be further arbitrated by a Data Sharing Independent Review Panel. Upon approval, information necessary to address the research question will be provided under the terms of a data sharing agreement. This may include anonymized individual patient data and/or available supporting documents, containing fragments of analysis code where provided in analysis specifications. Further details are available at the URL below.
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- SAV
- ICF
- CSR
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .